Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
リボヌクレオチド還元酵素R2を指向するアンチセンスオリゴヌクレオチドおよび癌の治療におけるこれらの使用
Document Type and Number:
Japanese Patent JP2006518344
Kind Code:
A
Abstract:
The present invention provides antisense oligonucleotides directed to a mammalian ribonucleotide reductase R2 gene and combinations of the antisense oligonucleotides with one or more chemotherapeutic agents for use in the treatment of cancer.

More Like This:
WO/2003/025167CULTURED STROMAL CELLS AND USES THEREOF
JP2005507666Methods and compositions for treating and diagnosing pain disorders using 2047
JP2022502041Compositions and Methods for the Treatment of Skin Diseases
Inventors:
Light, Jim A
Young, Aping H
Application Number:
JP2006501413A
Publication Date:
August 10, 2006
Filing Date:
February 10, 2004
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Genesense Technologies Inc.
International Classes:
A61K48/00; A61K31/282; A61K31/337; A61K31/7072; A61K31/7088; A61K45/00; A61P35/00; A61P35/02; C12N15/113; A61K38/00; C12N15/09
Domestic Patent References:
JP2000517167A2000-12-26
Foreign References:
WO2000047733A12000-08-17
WO2002085308A22002-10-31
Attorney, Agent or Firm:
Takahashi Kaname



 
Previous Patent: エネルギー減損因子を用いた良性前立腺増殖症の処置

Next Patent: 望ましくない微生物を抑制するためのピラゾリルカルボキシアニリド類